EIF2S1 and neuroblastoma: Importantly, our in vitro and in vivo experiments demonstrated that EIF2S1 silencing attenuated the aggressiveness of NB cells and resulted in a reduction in tumor burden in nude mice, providing important evidence supporting an oncogenic role of EIF2S1 in NB.